Tag: Drug delivery systems

Heparin is a critical anticoagulant typically administered by injection, but topical creams and gels are also common for certain conditions. This raises the important question for patients and clinicians alike: **Does heparin get absorbed through the skin** in a way that could produce systemic effects or is it limited to the local area of application?

Ocular inserts can increase the contact time of a medication on the eye's surface by up to 20 hours, significantly improving bioavailability compared to traditional eye drops. This advanced drug delivery system is classified primarily based on its solubility and drug release characteristics, offering various solutions for managing eye diseases.

Intravenously administered medications achieve 100% bioavailability, entering the bloodstream instantly and bypassing absorption hurdles. Understanding which form of medication is absorbed quicker is crucial in pharmacology for achieving rapid therapeutic effects and tailoring drug delivery to patient needs.

Sustained-release (SR) formulations were first developed in the 1950s and 1960s to improve treatment effectiveness [1.2.3]. The primary question for many patients is, **what is the use of one SR capsules?** They are designed to release medication slowly, enhancing patient compliance and therapeutic outcomes [1.2.3, 1.2.4].

According to one study, around 38,000 medication errors occur in the US each year due to confusing medical abbreviations and look-alike medication names. When deciphering a patient's chart or prescription, knowing what does SR mean in hospital is critical, as its meaning can change dramatically depending on the context, from 'sustained release' medication to 'sinus rhythm' in cardiology.

The global pharmaceutical drug delivery market was valued at approximately US$1.9 trillion in 2023 and is projected to grow, with oral delivery methods accounting for over 55% of the market share. Understanding **what are the different types of drug delivery** is crucial for appreciating advancements in modern medicine.

Mucoadhesive drug delivery systems can extend the time a medication stays at its target site from just a few minutes to several hours, significantly boosting its effectiveness. Understanding the answer to 'how does mucoadhesive work?' is key to developing next-generation targeted therapies.

In 2023, an estimated 6.0% of adults in the U.S. had a current ADHD diagnosis, which is equivalent to about 15.5 million people [1.7.1]. For many, stimulant medication is a key part of treatment, leading to questions like, **'Why does Mydayis last longer than Adderall XR?'**

With less than 5% of a topically applied drug dose typically reaching the intraocular tissues, developing effective ocular drug delivery systems is a major challenge due to the eye's natural barriers. This article explores the various methods of ocular drug delivery, highlighting how they are designed to bypass these protective mechanisms for targeted treatment.

According to the Food and Drug Administration (FDA), extended-release medications can be beneficial for many patients by improving adherence and reducing side effects. If you've ever seen the abbreviation XL on a prescription bottle and wondered, "**what does XL mean on meds?**", it indicates an extra-long, or extended-release, formulation designed for a longer duration of action.